Artwork

コンテンツは Karger Publishers によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Karger Publishers またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

S1 E5 – Breast Cancer Awareness with Abeda Steenkamp from CANSA

24:08
 
シェア
 

Manage episode 407348229 series 3559566
コンテンツは Karger Publishers によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Karger Publishers またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

The fifth and final episode of our special series on breast cancer for Karger’s Fast Facts Oncology Podcast. In episode we are joined by Abeda Steenkamp, breast cancer survivor and Service Coordinator for the Cancer Association of South Africa. Join us as we talk about stigma and taboos surrounding breast cancer in South Africa (CANSA). Furthermore, Abeda Kindly shares her own experiences as a breast cancer patient, discusses the important role of education and support, and gives an insight into her work and tasks as a Service Coordinator for CANSA. To accompany this series on breast cancer, Karger have produced a summary sheet showcasing the breast cancer highlights from this year’s ASCO 2022 meeting. The sheet is available to download for free from Karger’s platform - https://www.karger.com/WebMaterial/ShowFile/1449609

For more podcast episodes from Karger please visit karger.com/podcasts.

Fore more information about the work CANSA and the support that they provide please visit https://cansa.org.za/

This episode has been made possible by the contribution from Mylan Pharmaceuticals Private Limited, A Viatris Company. Viatris did not have any influence on the content and all items were subject to independent editorial review. These contents should not be construed to be medical, or consulting advice. The viewers assume all risk for use of the information and the content provided in the podcast episode. In no event shall Mylan Pharmaceuticals Private Limited or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages of any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has been informed of the possibility in advance, resulting from or in connection with the creation or use of or reliance in the podcast episode.

  continue reading

17 つのエピソード

Artwork
iconシェア
 
Manage episode 407348229 series 3559566
コンテンツは Karger Publishers によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Karger Publishers またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

The fifth and final episode of our special series on breast cancer for Karger’s Fast Facts Oncology Podcast. In episode we are joined by Abeda Steenkamp, breast cancer survivor and Service Coordinator for the Cancer Association of South Africa. Join us as we talk about stigma and taboos surrounding breast cancer in South Africa (CANSA). Furthermore, Abeda Kindly shares her own experiences as a breast cancer patient, discusses the important role of education and support, and gives an insight into her work and tasks as a Service Coordinator for CANSA. To accompany this series on breast cancer, Karger have produced a summary sheet showcasing the breast cancer highlights from this year’s ASCO 2022 meeting. The sheet is available to download for free from Karger’s platform - https://www.karger.com/WebMaterial/ShowFile/1449609

For more podcast episodes from Karger please visit karger.com/podcasts.

Fore more information about the work CANSA and the support that they provide please visit https://cansa.org.za/

This episode has been made possible by the contribution from Mylan Pharmaceuticals Private Limited, A Viatris Company. Viatris did not have any influence on the content and all items were subject to independent editorial review. These contents should not be construed to be medical, or consulting advice. The viewers assume all risk for use of the information and the content provided in the podcast episode. In no event shall Mylan Pharmaceuticals Private Limited or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages of any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has been informed of the possibility in advance, resulting from or in connection with the creation or use of or reliance in the podcast episode.

  continue reading

17 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド